These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5581314)

  • 41. [Modification of insulin-secretion, induced by glucose, of the isolation-perfused rat pancreas using tolbutamide, glucosamine, diazoxide, glucagon and endogenous insulin].
    Bierwolf B; Blech W
    Acta Biol Med Ger; 1976; 35(5):583-95. PubMed ID: 983609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
    Mariani MM
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
    [No Abstract]   [Full Text] [Related]  

  • 43. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.
    Bressler R; Vargas-Cord M; Lebovitz HE
    Diabetes; 1968 Oct; 17(10):617-24. PubMed ID: 4878653
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of a monoamine oxidase inhibitor (mebanazine) on brain glucose-6-phosphate dehydrogenase activity.
    Zor U; Locker D; Schleider M; Sulman FG
    Eur J Pharmacol; 1967 Dec; 2(3):193-5. PubMed ID: 5590342
    [No Abstract]   [Full Text] [Related]  

  • 45. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 46. Spinal monoamines and the toxic interaction between monoamine oxidase inhibitors and tricyclic antidepressants.
    Clineschmidt BV
    Eur J Pharmacol; 1972 Jul; 19(1):126-9. PubMed ID: 4403107
    [No Abstract]   [Full Text] [Related]  

  • 47. MODIFICATION OF THE HYPOGLYCAEMIC RESPONSE TO TOLBUTAMIDE AND INSULIN BY MEBANAZINE--AN INHIBITOR OF MONOAMINE OXIDASE.
    BARRETT AM
    J Pharm Pharmacol; 1965 Jan; 17():19-27. PubMed ID: 14285690
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies of insulin secretion in the perfused rat pancreas. Effect of diazoxide and A025.
    Basabe J; Lopez N; Viktora J; Wolff F
    Diabetes; 1970 Apr; 19(4):271-81. PubMed ID: 5437980
    [No Abstract]   [Full Text] [Related]  

  • 49. Pancreatic insulin secretion following intrapancreatic infusion of amino acid.
    Colwell AR; Zuckerman L; Berger S
    Diabetes; 1970 Apr; 19(4):217-27. PubMed ID: 4910037
    [No Abstract]   [Full Text] [Related]  

  • 50. Longitudinal studies of the effect of monoamine oxidase inhibitors on sleep in man.
    Wyatt RJ; Kupfer DJ; Scott J; Robinson DS; Snyder F
    Psychopharmacologia; 1969; 15(3):236-44. PubMed ID: 4310849
    [No Abstract]   [Full Text] [Related]  

  • 51. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
    Lundquist I; Ekholm R; Ericson LE
    Diabetologia; 1971 Dec; 7(6):414-22. PubMed ID: 5004176
    [No Abstract]   [Full Text] [Related]  

  • 52. Proinsulin and insulin release with a human insulinoma and adjacent nonadenomatous pancreas.
    Gutman RA; Fink G; Shapiro JR; Selawry H; Recant L
    J Clin Endocrinol Metab; 1973 May; 36(5):978-87. PubMed ID: 4349051
    [No Abstract]   [Full Text] [Related]  

  • 53. Potentiation of the mydriatic effect of norepinephrine in the rabbit after monoamine oxidase inhibition.
    Colasanti BK; Bárány EH
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):200-3. PubMed ID: 33123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interaction between anti-MAO and adrenomedullary catecholamines. I. Histochemical studies of the catecholamine content of the adrenal medulla of the rat treated with mebanazine].
    Tessitore V
    Boll Soc Ital Biol Sper; 1967 Aug; 43(15):894-6. PubMed ID: 6056695
    [No Abstract]   [Full Text] [Related]  

  • 55. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 56. The stimulus-secretion coupling of glucose-induced insulin release. 3. Uptake of 45 calcium by isolated islets of Langerhans.
    Malaisse-Lagae F; Malaisse WJ
    Endocrinology; 1971 Jan; 88(1):72-80. PubMed ID: 4921884
    [No Abstract]   [Full Text] [Related]  

  • 57. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of diphenylhydantoin and diazoxide to investigate insulin secretory mechanisms.
    Levin SR; Charles MA; O'connor M; Grodsky GM
    Am J Physiol; 1975 Jul; 229(1):49-54. PubMed ID: 1147055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanisms of catecholamine inactivation by the endocrine pancreas.
    Feldman JM; Chapman B
    Diabetes; 1974 Sep; 23(9):754-62. PubMed ID: 4606797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.